Never having to say you’re sorry

bull's eye view photo

For Wall Street, that’s what it means apparently. Torn over whether a Biden win brings joy or misery. Really.

Those with the rosier outlook point to Biden’s mostly pro-business inner circle, his significant campaign contributions from the financial industry and his longtime support of credit card companies located in his home state of Delaware. Plus, a Biden victory would likely be driven by U.S. voters seeking change because they believe the country is a mess. Wall Street thinks it has a strong argument to make that reining in lenders would be a fatal mistake when unemployment is sky-high and the economy remains ravaged by the coronavirus pandemic.

The enthusiasm, however, is tempered by fears over how much sway Biden will give progressives and their firebrand leaders, including Senators Elizabeth Warren and Bernie Sanders. That’s especially true when it comes to picking appointees to run the powerful agencies that police banks and securities firms, jobs that the activists are mobilizing to fill with industry critics. At a minimum, progressives want to ensure that the days are long over when Democrats appointed officials like Robert Rubin, Timothy Geithner and Lawrence Summers, who is a key Biden adviser.

The stakes for Wall Street couldn’t be higher. Centrist regulators would be less likely to overturn rule rollbacks approved under Trump that have saved financial firms tens of billions of dollars. Progressive agency heads, on the other hand, could pursue what the C-suite calls the “shame and investigation agenda.” Policies like taxes on trading, curbs on executive pay and even breaking up behemoth banks would be back on the table.

To wonder whether ‘Wall Street’ has some understanding of our current morass, much less the words ‘joy’ or ‘ misery,’ is to weep. Of course they do. Always check the business press if you’re wondering at all about the soul of a consumer society. Mantra for post-2016 world: it’s always worse than you think.

Image: Replica golden calf. Subtlety is NOT their strong point.

Windy names for fun

Why can’t the pharmaceutical companies

The United States is on the verge of a solar boom that could provide 4.3 percent of the nation’s electricity by 2020, according to a new report from Bloomberg New Energy Finance.

There’s just a 12-figure catch: Investors need to put $100 billion into the solar industry to keep the generation of solar electricity growing by 42 percent a year for the next decade to expand capacity from the current 1.4 gigawatts to 44 gigawatts

directly fund sponsor desert wind farms?

Federal prosecutors in Boston yesterday said British drug giant GlaxoSmithKline PLC agreed to pay $750 million to settle civil and criminal charges that it made and sold adulterated drugs, including the antidepressant Paxil, to Medicaid and other government payers

The settlement, one of the largest ever in a health care fraud case, burnished the reputation of the US attorney’s office in Boston as the premier federal office for investigating health care fraud. It has been responsible for recovering about $6 billion in health care fines and claims in the past decade, about 25 percent of all recoveries nationally.

If you think I’ve got it backwards, GlaxosmithKline’s share price only went down .14 (fourteen cents!) on news of the settlement.